These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 39007865)
1. Oncogenic R248W mutation induced conformational perturbation of the p53 core domain and the structural protection by proteomimetic amyloid inhibitor ADH-6. Liu Q; Yu Y; Wei G Phys Chem Chem Phys; 2024 Jul; 26(29):20068-20086. PubMed ID: 39007865 [TBL] [Abstract][Full Text] [Related]
2. Elucidating the Mechanisms of R248Q Mutation-Enhanced p53 Aggregation and Its Inhibition by Resveratrol. Liu Q; Li L; Yu Y; Wei G J Phys Chem B; 2023 Sep; 127(36):7708-7720. PubMed ID: 37665658 [TBL] [Abstract][Full Text] [Related]
3. Distinct modulatory role of RNA in the aggregation of the tumor suppressor protein p53 core domain. Kovachev PS; Banerjee D; Rangel LP; Eriksson J; Pedrote MM; Martins-Dinis MMDC; Edwards K; Cordeiro Y; Silva JL; Sanyal S J Biol Chem; 2017 Jun; 292(22):9345-9357. PubMed ID: 28420731 [TBL] [Abstract][Full Text] [Related]
4. Molecular dynamics study on the inhibition mechanisms of ReACp53 peptide for p53-R175H mutant aggregation. Lei J; Cai M; Shen Y; Lin D; Deng X Phys Chem Chem Phys; 2021 Oct; 23(40):23032-23041. PubMed ID: 34612239 [TBL] [Abstract][Full Text] [Related]
5. Aggregation-primed molten globule conformers of the p53 core domain provide potential tools for studying p53C aggregation in cancer. Pedrote MM; de Oliveira GAP; Felix AL; Mota MF; Marques MA; Soares IN; Iqbal A; Norberto DR; Gomes AMO; Gratton E; Cino EA; Silva JL J Biol Chem; 2018 Jul; 293(29):11374-11387. PubMed ID: 29853637 [TBL] [Abstract][Full Text] [Related]
6. Biophysical characterization of p53 core domain aggregates. Lima I; Navalkar A; Maji SK; Silva JL; de Oliveira GAP; Cino EA Biochem J; 2020 Jan; 477(1):111-120. PubMed ID: 31841126 [TBL] [Abstract][Full Text] [Related]
7. Common cancer mutations R175H and R273H drive the p53 DNA-binding domain towards aggregation-prone conformations. Li L; Li X; Tang Y; Lao Z; Lei J; Wei G Phys Chem Chem Phys; 2020 May; 22(17):9225-9232. PubMed ID: 32307496 [TBL] [Abstract][Full Text] [Related]
8. Multiscale simulations reveal the driving forces of p53C phase separation accelerated by oncogenic mutations. Yu Y; Liu Q; Zeng J; Tan Y; Tang Y; Wei G Chem Sci; 2024 Aug; 15(32):12806-12818. PubMed ID: 39148776 [TBL] [Abstract][Full Text] [Related]
9. Mutant p53 aggregates into prion-like amyloid oligomers and fibrils: implications for cancer. Ano Bom AP; Rangel LP; Costa DC; de Oliveira GA; Sanches D; Braga CA; Gava LM; Ramos CH; Cepeda AO; Stumbo AC; De Moura Gallo CV; Cordeiro Y; Silva JL J Biol Chem; 2012 Aug; 287(33):28152-62. PubMed ID: 22715097 [TBL] [Abstract][Full Text] [Related]
10. Insights into Allosteric Mechanisms of the Lung-Enriched p53 Mutants V157F and R158L. Lei J; Li X; Cai M; Guo T; Lin D; Deng X; Li Y Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077492 [TBL] [Abstract][Full Text] [Related]
11. Relevance of Amorphous and Amyloid-Like Aggregates of the p53 Core Domain to Loss of its DNA-Binding Activity. Hibino E; Tenno T; Hiroaki H Front Mol Biosci; 2022; 9():869851. PubMed ID: 35558561 [TBL] [Abstract][Full Text] [Related]
12. Protein mimetic amyloid inhibitor potently abrogates cancer-associated mutant p53 aggregation and restores tumor suppressor function. Palanikumar L; Karpauskaite L; Al-Sayegh M; Chehade I; Alam M; Hassan S; Maity D; Ali L; Kalmouni M; Hunashal Y; Ahmed J; Houhou T; Karapetyan S; Falls Z; Samudrala R; Pasricha R; Esposito G; Afzal AJ; Hamilton AD; Kumar S; Magzoub M Nat Commun; 2021 Jun; 12(1):3962. PubMed ID: 34172723 [TBL] [Abstract][Full Text] [Related]
13. Expanding the prion concept to cancer biology: dominant-negative effect of aggregates of mutant p53 tumour suppressor. Silva JL; Rangel LP; Costa DC; Cordeiro Y; De Moura Gallo CV Biosci Rep; 2013 Jul; 33(4):. PubMed ID: 24003888 [TBL] [Abstract][Full Text] [Related]
14. Targeting the Prion-like Aggregation of Mutant p53 to Combat Cancer. Silva JL; Cino EA; Soares IN; Ferreira VF; A P de Oliveira G Acc Chem Res; 2018 Jan; 51(1):181-190. PubMed ID: 29260852 [TBL] [Abstract][Full Text] [Related]
15. Water Leakage Pathway Leads to Internal Hydration of the p53 Core Domain. Lima IDM; Pedrote MM; Marques MA; Sousa GDS; Silva JL; de Oliveira GAP; Cino EA Biochemistry; 2023 Jan; 62(1):35-43. PubMed ID: 36535020 [TBL] [Abstract][Full Text] [Related]
16. R248Q mutation--Beyond p53-DNA binding. Ng JW; Lama D; Lukman S; Lane DP; Verma CS; Sim AY Proteins; 2015 Dec; 83(12):2240-50. PubMed ID: 26442703 [TBL] [Abstract][Full Text] [Related]
17. Cognate DNA stabilizes the tumor suppressor p53 and prevents misfolding and aggregation. Ishimaru D; Ano Bom AP; Lima LM; Quesado PA; Oyama MF; de Moura Gallo CV; Cordeiro Y; Silva JL Biochemistry; 2009 Jul; 48(26):6126-35. PubMed ID: 19505151 [TBL] [Abstract][Full Text] [Related]
19. Oncogenic p53 triggers amyloid aggregation of p63 and p73 liquid droplets. Petronilho EC; de Andrade GC; de Sousa GDS; Almeida FP; Mota MF; Gomes AVDS; Pinheiro CHS; da Silva MC; Arruda HRS; Marques MA; Vieira TCRG; de Oliveira GAP; Silva JL Commun Chem; 2024 Sep; 7(1):207. PubMed ID: 39284933 [TBL] [Abstract][Full Text] [Related]
20. Effect of Mutation on an Aggregation-Prone Segment of p53: From Monomer to Dimer to Multimer. Das A; Makarov DE J Phys Chem B; 2016 Nov; 120(45):11665-11673. PubMed ID: 27775362 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]